This was performed by evaluating the expression of syndecans 1–4 and the binding potential of endogenously expressed TFPI to syndecans on the cell surface of primary human endothelial- and smooth muscle cells, and basal breast cancer cells. The gene discussed is TFPI; the disease is breast cancer.